Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MHC transmission: insights into gender bias in MS susceptibility.
Environmental, modifiable risk factors for multiple sclerosis
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System.
National MS Society: Postdoctoral Fellowships
Cognitive Test Analysis May Determine Reliable MS Change Over Time
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Keystone Symposium: Neuroepigenetics
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
29th European Committee for Treatment and Research in Multiple Sclerosis Congress
Episode 27 with Dr. Brenda Banwell on the new journal Multiple Sclerosis and Related Disorders
Sex differences in autoimmune disease.
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Episode 1 with Dr. Timothy Vollmer on maintaining brain health
A New Colour Reaction on Copper and Certain Carbonyl Compounds
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity.
Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Pages
« first
‹ previous
…
51
52
53
54
55
56
57
58
59
…
next ›
last »